You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Follow
Planning
Aligning Health Care Industry Cybersecurity Approaches
ASPR Playbooks
At-Risk, Behavioral Health...(ABC)
Coming in 2022: RISC Toolkit 2.0
Critical Infrastructure Protection
Cybersecurity TF
EPAP
Evaluation Branch
Gaps in Contraception Access and Zika
Health Care Readiness
HPP
Incident Response Framework
Last Mile
Legal Authority and Other Guidance
Medical Planning and Response Manual for a Nuclear Detonation Incident: A Practical Guide
Medical Surge Capacity Capability
National Emergency Tele Critical Care Network (NETCCN)
National Influenza Vaccine Modernization Strategy 2020-2030
National Plus
Notice of Funding Opportunity EP-HIT-21-004
International Preparedness and Response
International CONOPS
Security and Prosperity Partnership
Southern Caucasus Collaboration and Partnership in Countering Biological Threats
Outbreak Response and Bioterrorism Investigation Trilateral Forum
Countering Biological Threats
North American Plan for Animal and Pandemic Influenza
U.S. Health Security National Action Plan: Strengthening Implementation of the International Health Regulations
Medical Countermeasures
HHS Retrospective on the 2009 H1N1 Influenza Pandemic
PHEMCE
BARDA Funds Medical Countermeasure Innovation
HHS Centers for Innovation in Advanced Development and Manufacturing
BARDA evaluates burn dressing for radiation, sulfur mustard burns
BARDA funds study of therapy for thermal burns
HHS explores new emergency response use for approved steroid
HHS funds development of freeze-dried platelets for disaster response
BARDA funds development of device to aid burn patients in disasters
New blood test would provide fast results for medical care after anthrax attack
BARDA boosts global ability to respond to pandemics
New diagnostic test to detect the presence of an influenza virus and identify its genetic profile
New device could reduce time needed to test for bacteria, such as anthrax
Mass decontamination research provides new scientific evidence for responders, hospitals to decontaminate chemical terrorism, accident survivors
HHS pursues fast, easy test for anthrax and multi-drug resistant anthrax infections
HHS pursues development of panels of blood-based biomarkers for several biothreat pathogens
BARDA funds advanced development of drug to treat injuries from exposure to cyanide
BARDA supports development of antitoxin administered as a traditional shot
BARDA funds development of drugs to treat injuries from chemical bioterrorism
Public Health and Medical Services Support
Emergency Preparedness
Emergency Support Function
Legal Authority of the Secretary
Medical Assistance
Medical Response
Medical Surge Capacity Capability
EMS and First Responders
Responders Clinicians & Practitioners
National Disaster Medical System
Regional Emergency Coordinators
Secretary's Operations Center
Guidance for Protecting Responders’ Health During the First Week Following A Wide-Area Aerosol Anthrax Attack
Frequently Asked Questions
Patient Decontamination Following Chemical Incidents
Ebola Preparedness for the U.S. Healthcare System
Response to Comments for Patient Decontamination in a Mass Chemical Exposure Incident: National Planning Guidance for Communities
National Survey of Health Insurance Plan Emergency Preparedness Report
Legal Authorities
Boards and Committees
Guidance
Pandemic and All Hazards Preparedness Act (PAHPA)
Public Health Resources
Public Readiness and Emergency Preparedness (PREP) Act
Public Health Emergency Declaration Q&As
Redirect to Public Health Emergency Declaration on aspr.hhs.gov
Redirect to About 1135 Waivers
COVID-19: Coronavirus Disease 2019
ASPR Redirect Page
Redirect to ASPR COVID-19 News
National Biodefense Strategy
2019 Biodefense Public Report
National Biodefense Strategy
Biodefense Summit
About the Biodefense Summit
Call for Public Comments: National Biodefense Strategy Implementation
Biodefense Summit Transcripts
Welcome Remarks
Opening Remarks
Importance of the Biodefense Summit
Evolution of U.S. Biodefense Policy
Recommendation and Perspective of the Blueprint for Biodefense
Goal 1: Enabling Risk Awareness to Inform Decision Making across the Biodefense Enterprise
Goal 1: Discussion Questions and Answers
Goal 2: Ensure Biodefense Enterprise Capabilities to Prevent Bioincidents
Goal 2: Discussion Questions and Answers
Goal 3: Ensure Biodefense Preparedness Enterprise to Reduce the Impacts of Bioincidents
Goal 3: Discussion Questions and Answers
Site Contents
Skip over global navigation links
Office of the Assistant Secretary for Preparedness and Response
Preparedness
Emergency
About ASPR
Public Health Emergency - Leading a Nation Prepared
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
PHE Home
>
Preparedness
Preparedness News Releases
Main Content
URL
December 28, 2021: HHS activates Emergency Prescription Assistance Program for uninsured Kentucky residents needing medicine after recent tornadoes
December 23, 2021: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults
December 22, 2021: FDA Authorizes First Oral Antiviral for Treatment of COVID-19
December 08, 2021: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals
December 03, 2021: FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns
November 18, 2021: Biden Administration Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine as Additional Tool to Reduce Hospitalizations and Save Lives
October 5, 2021: HHS selects Emory University to demonstrate better approach to disaster medical care
September 13, 2021: HHS Activates Emergency Prescription Assistance Program for Uninsured Residents of Louisiana Due to Hurricane Ida
September 3, 2021: HHS Secretary Becerra declares public health emergencies for states of New York and New Jersey due to Hurricane Ida
August 30, 2021: HHS Secretary Becerra declares public health emergencies for states of Louisiana and Mississippi due to Hurricane Ida
July 9, 2021: Statement by HHS Secretary Xavier Becerra on the Swearing-In of Dawn O’Connell as Assistant Secretary for Preparedness and Response and Cheryl Campbell becoming Assistant Secretary for Administration
June 30, 2021: HHS launches calculator tool to help health administrators, clinicians improve capacity to treat COVID-19 patients with monoclonal antibodies
June 23, 2021: HHS, Puerto Rico Department of Health test health and social services recovery efforts with preparedness exercise in Mayagüez healthcare region
23 de junio de 2021: HHS junto al Departamento de Salud de Puerto Rico evalúa los esfuerzos de recuperación de servicios sociales y de salud con el ejercicio de preparación en la región de atención médica de Mayagüez
June 17, 2021: Biden Administration to Invest $3 Billion from American Rescue Plan as Part of COVID-19 Antiviral Development Strategy
June 9, 2021: Biden Administration announces U.S. government procurement of Merck’s investigational antiviral medicine for COVID-19 treatment
June 8, 2021: Biden Administration Recommends Policy Changes to Secure U.S. Pharmaceutical Supply Chain
June 1, 2021: HHS Launches First Venture Capital Partnership to Develop Transformative Technologies to Combat Future Pandemics, Other Health Emergencies
May 26, 2021: Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19
April 16, 2021: Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab
April 15, 2021: Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of Coronavirus Disease 2019 (COVID-19) Pandemic
April 9, 2021: Statement by HHS Secretary Xavier Becerra on the President’s FY 2022 Discretionary Funding Request
March 25, 2021: Medical Reserve Corps volunteers aid COVID-19 vaccination efforts in 46 states and U.S. territories
March 17, 2021: Biden Administration to Invest $150 Million to Expand Access to COVID-19 Treatments in Underserved Communities
March 12, 2021: Biden Administration Takes Action Through HHS to Increase Number of Vaccinators
March 2, 2021: Biden Administration Announces Historic Manufacturing Collaboration Between Merck and Johnson & Johnson to Expand Production of COVID-19 Vaccines
February 26, 2021: Biden Administration secures supply of new COVID-19 therapeutic treatment
February 18, 2021: HHS Acting Secretary Norris Cochran Declares Public Health Emergency for State of Texas Due to Winter Storms
February 11, 2021: Biden Administration purchases additional doses of COVID-19 vaccines from Pfizer and Moderna
January 28, 2021: HHS Amends PREP Act Declaration to Increase Workforce Authorized to Administer COVID-19 Vaccines
January 15, 2021: HHS launches COVID-19 at-risk Medicare population dashboard, related online tools to support COVID-19 response
January 12, 2021: HHS, DOD purchase additional doses of Regeneron’s antibody therapeutic to treat patients with mild to moderate COVID-19
January 11, 2021: HHS Launches Web-Based Locator for COVID-19 Outpatient Treatment Sites for Monoclonal Antibodies
January 11, 2021: HHS Launches Web-Based Locator for COVID-19 Outpatient Treatment Sites for Monoclonal Antibodies
January 8, 2021: HHS, Sunrise Hospital Launch Federally Supported Monoclonal Antibody Infusion Clinic to Treat COVID-19 Patients in Las Vegas
January 7, 2021: HHS, Tucson Medical Center launch federally supported infusion center to treat COVID-19 patients
December 30, 2020: HHS, El Centro Regional Medical Center launch Imperial County Infusion Center to treat COVID-19 patients
December 23, 2020: HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment
December 23, 2020: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer
December 15, 2020: HHS, DOD engage Quantum Leap Research Collaborative in search for effective treatments for the sickest COVID-19 patients
December 11, 2020: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Moderna
December 2, 2020: Trump Administration purchases additional doses of Lilly therapeutic to treat patients with mild to moderate COVID-19
November 23, 2020: HHS Allocates Regeneron Therapeutic to Treat Patients With Mild to Moderate COVID-19
October 30, 2020: Trump Administration Producing Supply Kits to Safely Administer COVID-19 Vaccines to Americans
October 28, 2020: HHS, DOD Collaborate on Plans to Purchase of Lilly Investigational Therapeutic to Treat COVID-19
October 23, 2020: HHS Delivers 125 Million Masks to Support Safe School Reopening
October 13, 2020: Trump Administration Expands Manufacturing Capacity with Cytiva for Components of COVID-19 Vaccines
October 9, 2020: Trump Administration Expands Collaboration with AstraZeneca to Develop and Manufacture an Investigational Monoclonal Antibody to Prevent COVID-19
October 6, 2020: HHS funds development of needle-free vaccine administration technology
October 1, 2020: Veklury (remdesivir) Now Available Directly from Distributor following Trump Administration’s Successful Allocations to States and U.S. Territories
1 - 50
Compliance Details
javascript:commonShowModalDialog('{SiteUrl}'+ '/_layouts/15/itemexpiration.aspx' +'?ID={ItemId}&List={ListId}', 'center:1;dialogHeight:500px;dialogWidth:500px;resizable:yes;status:no;location:no;menubar:no;help:no', function GotoPageAfterClose(pageid){if(pageid == 'hold') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/hold.aspx' +'?ID={ItemId}&List={ListId}'); return false;} if(pageid == 'audit') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/Reporting.aspx' +'?Category=Auditing&backtype=item&ID={ItemId}&List={ListId}'); return false;} if(pageid == 'config') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/expirationconfig.aspx' +'?ID={ItemId}&List={ListId}'); return false;}}, null);
0x0
0x1
ContentType
0x01
898
Document Set Version History
/_layouts/15/images/versions.gif?rev=23
javascript:SP.UI.ModalDialog.ShowPopupDialog('{SiteUrl}'+ '/_layouts/15/DocSetVersions.aspx' + '?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
330
Send To other location
/_layouts/15/images/sendOtherLoc.gif?rev=23
javascript:GoToPage('{SiteUrl}' + '/_layouts/15/docsetsend.aspx' + '?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
350
Right Box1 Content
Right Box2 Content
Stay Up To Date with PHE.gov
Newsroom
Watch, Listen, Subscribe
This page last reviewed: August 05, 2020
